Novanta Inc. (LON:0VAG)
London flag London · Delayed Price · Currency is GBP · Price in USD
122.05
-5.65 (-4.42%)
At close: Jul 18, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Automation Enabling Technologies
490.62M
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Growth
1.59%
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Post-Q3 2024 Reporting)
458.63M
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Post-Q3 2024 Reporting) Growth
12.46%
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing
-
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Pre-Q4 2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Pre-Q4 2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation
288.32M
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Growth
14.71%
Log In
Log In
Log In
Log In
Upgrade
Other
660.93M
Log In
Log In
Log In
Log In
Upgrade
Other
660.93M
Log In
Log In
Log In
Log In
Upgrade
Other
660.93M
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
179.85M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate and Shared Services Operating Income
-53.35M
Log In
Log In
Log In
Log In
Upgrade
Corporate and Shared Services Operating Income Growth
1.83%
Log In
Log In
Log In
Log In
Upgrade
Other
179.85M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Operating Income
106.40M
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Operating Income Growth
17.92%
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Post-Q3 2024 Reporting)
57.53M
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Post-Q3 2024 Reporting) Growth
-13.64%
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Pre-Q4 2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Pre-Q4 2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
179.85M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Gross Income by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
427.71M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
427.71M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate and Shared Services Gross Profit
-3.39M
Log In
Log In
Log In
Log In
Upgrade
Corporate and Shared Services Gross Profit Growth
-24.08%
Log In
Log In
Log In
Log In
Upgrade
Other
427.71M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Gross Profit
234.98M
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Gross Profit Growth
7.00%
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Post-Q3 2024 Reporting)
189.96M
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Post-Q3 2024 Reporting) Growth
-0.56%
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Gross Profit
-
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Pre-Q4 2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Gross Profit
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
487.11M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
14.41%
Log In
Log In
Log In
Log In
Upgrade
Germany
123.24M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-6.33%
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe
128.87M
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Growth
-6.46%
Log In
Log In
Log In
Log In
Upgrade
China
84.56M
Log In
Log In
Log In
Log In
Upgrade
China Growth
22.29%
Log In
Log In
Log In
Log In
Upgrade
Rest of Asia-Pacific
107.05M
Log In
Log In
Log In
Log In
Upgrade
Rest of Asia-Pacific Growth
-1.26%
Log In
Log In
Log In
Log In
Upgrade
Other Geographic
18.40M
Log In
Log In
Log In
Log In
Upgrade
Other Geographic Growth
-9.52%
Log In
Log In
Log In
Log In
Upgrade